tiprankstipranks
Biocure Technology Inc (TSE:CURE)
CNQX:CURE

Biocure Technology Inc (CURE) Cash flow

4 Followers

Biocure Technology Inc Cash Flow

TSE:CURE's free cash flow for Q3 2023 was C$-6.19K. For the 2023 fiscal year, TSE:CURE's free cash flow was decreased by C$257.40K and operating cash flow was C$-6.19K. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
C$ -450.37KC$ -825.92KC$ -1.08MC$ -1.31MC$ -2.68MC$ -2.59M
Investing Cash Flow
C$ 118.31KC$ 74.80KC$ -3.94KC$ 91.49KC$ -1.05MC$ -972.95K
Financing Cash Flow
C$ 282.40KC$ 630.93KC$ 1.17MC$ 1.13MC$ 3.69MC$ 2.60M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
C$ -53.16KC$ 38.51KC$ 159.10KC$ 46.68KC$ 132.44KC$ 108.62K
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
--C$ 1.10MC$ 985.38KC$ 1.76MC$ 0.00
Issuance Of Debt
C$ -27.84K-C$ 70.53KC$ 401.58KC$ 1.99MC$ 784.31K
Repayment Of Debt
C$ 3.55K-C$ -102.02KC$ -253.00KC$ -59.39K-
Free Cash Flow
C$ -450.16KC$ -825.92KC$ -1.08MC$ -1.31MC$ -3.73MC$ -3.53M
Domestic Sales
------
Foreign Sales
------
Currency in CAD

Biocure Technology Inc Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis